Bortezomib will improve the level or outcome of flibanserin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Monitor. Enhanced flibanserin adverse effects may perhaps manifest if coadministered with several weak CYP3A4 inhibitors. lenacapavir will enhance the stage or result of bortezomib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Chec... https://dickr988myi4.blogadvize.com/profile